Acalabrutinib
Update Venetoclax in CLL
Obinutuzumab
Zanubrutinib
NCCN COVID-19 Resources Page
Leukemia & Lymphoma Society
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
UpToDate